Vimarsana
Biggest News Aggregation in the World

Portfolio Integration News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Portfolio Integration. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Portfolio Integration Today - Breaking & Trending Today

SUSE Enhances Cloud Native Portfolio to Manage Diverse Cloud Native Environments at Scale - Vimarsana News

SUSE Enhances Cloud Native Portfolio to Manage Diverse Cloud Native Environments at Scale

/PRNewswire/ -- (KubeCon North America) -- SUSE®, the company behind SUSE Linux Enterprise (SLE), Rancher and NeuVector, today announced the availability of...

Helsinn appoints Dr Melanie Rolli as Group Chief Operating - Vimarsana News

Helsinn appoints Dr Melanie Rolli as Group Chief Operating

Helsinn appoints Dr Melanie Rolli as Group Chief Operating Officer Lugano, Switzerland, May 19, 2022 – Helsinn Group, a fully integrated, global biopharma...

Helsinn Healthcare S.A.: Helsinn appoints Dr Melanie Rolli as Group Chief Operating Officer - Vimarsana News

Helsinn Healthcare S.A.: Helsinn appoints Dr Melanie Rolli as Group Chief Operating Officer

Helsinn appoints Dr Melanie Rolli as Group Chief Operating Officer Lugano, Switzerland, May 19, 2022 - Helsinn Group, a fully integrated, global biopharma company with a diversified pipeline

Helsinn appoints Dr Melanie Rolli as Group Chief Operating Officer - Vimarsana News

Helsinn appoints Dr Melanie Rolli as Group Chief Operating Officer

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

Source: apnews.com
Wellcome grants €1.3M to RCSI to develop prognostic blood test for psychotic disorders - Vimarsana News

Wellcome grants €1.3M to RCSI to develop prognostic blood test for psychotic disorders

 E-Mail RCSI University of Medicine and Health Sciences has received a €1.3 million grant from Wellcome to further develop a blood test that can predict whether a person is likely to develop a psychotic disorder years later. The researchers had previously analysed blood samples taken from people at clinical high risk of psychosis. These individuals were followed up for several years to see who did and did not develop a psychotic disorder. After assessing the proteins in blood samples and using machine learning to analyse this data, the scientists were able to find patterns of proteins in t...